GAMMA Investing LLC Has $2.14 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

GAMMA Investing LLC raised its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 14,805.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,036 shares of the medical instruments supplier's stock after acquiring an additional 17,915 shares during the quarter. GAMMA Investing LLC owned approximately 0.33% of Mesa Laboratories worth $2,140,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Mesa Laboratories by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 382,856 shares of the medical instruments supplier's stock worth $50,487,000 after purchasing an additional 5,274 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Mesa Laboratories during the fourth quarter worth approximately $32,677,000. Ameriprise Financial Inc. raised its stake in Mesa Laboratories by 191.8% during the 4th quarter. Ameriprise Financial Inc. now owns 151,862 shares of the medical instruments supplier's stock valued at $20,026,000 after purchasing an additional 99,819 shares during the last quarter. Northern Trust Corp boosted its holdings in Mesa Laboratories by 2.0% in the 4th quarter. Northern Trust Corp now owns 93,789 shares of the medical instruments supplier's stock valued at $12,368,000 after purchasing an additional 1,825 shares during the period. Finally, Janus Henderson Group PLC grew its position in Mesa Laboratories by 10.3% during the fourth quarter. Janus Henderson Group PLC now owns 86,286 shares of the medical instruments supplier's stock worth $11,379,000 after buying an additional 8,092 shares in the last quarter. Institutional investors and hedge funds own 90.60% of the company's stock.

Insider Transactions at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the transaction, the chief executive officer now owns 43,337 shares of the company's stock, valued at $5,369,887.67. The trade was a 32.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.40% of the stock is currently owned by insiders.

Mesa Laboratories Trading Up 0.4%

Mesa Laboratories stock traded up $0.38 during mid-day trading on Monday, hitting $97.48. The stock had a trading volume of 30,832 shares, compared to its average volume of 44,058. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $155.12. The stock has a 50-day simple moving average of $112.42 and a two-hundred day simple moving average of $125.84. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $531.75 million, a PE ratio of -2.10 and a beta of 0.88.

Mesa Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 annualized dividend and a yield of 0.66%. Mesa Laboratories's dividend payout ratio is presently -172.97%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MLAB. Wells Fargo & Company reduced their price objective on shares of Mesa Laboratories from $120.00 to $100.00 and set an "underweight" rating for the company in a report on Friday, May 30th. Wall Street Zen cut Mesa Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, May 30th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.